Mitochondrial Transplantation: An Emerging Therapeutic Option for Cardiovascular Disease
Korean Circulation Journal · 2027 · 57
DOI: 10.4070/kcj.2026.0074 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Korean Circulation Journal, 2027. Verfasst von Suin Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Chung-Ang University Hospital, College of Medicine, Chung-Ang University, Seoul, Korea. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Chung-Ang University, Korean Cardiac Research Foundation.
Abstract (Originalsprache)
Cardiovascular diseases (CVD) continue to impose the greatest global burden of death, and mitochondrial injury is increasingly recognized as a key pathological driver across ischemic heart disease, cardiac arrest, and heart failure. In this context, mitochondrial transplantation (MT) has gained attention as a promising therapeutic approach that directly addresses bioenergetic deficits by delivering functional mitochondria to compromised myocardium. This review examines current evidence for MT in CVD and evaluates its translational potential. We comprehensively reviewed preclinical studies and early clinical data on MT in CVD models, focusing on isolation techniques, delivery mechanisms, cellular uptake pathways, and therapeutic outcomes. Key databases were searched for relevant studies published through November 2025. MT demonstrates significant cardioprotective effects across diverse CVD models, including reduction in infarct size, restoration of adenosine triphosphate production, and improved functional recovery. Multiple cellular uptake mechanisms have been investigated, including actin-dependent endocytosis, macropinocytosis, and tunneling nanotubes. Advanced delivery strategies incorporating surface modifications, hydrogel platforms, and targeted peptides have improved mitochondrial stability and homing efficiency. Proposed mechanisms extend beyond bioenergetic rescue to include modulation of autophagy, oxidative stress reduction, and immunometabolic regulation. However, critical challenges remain regarding uptake efficiency, biodistribution, persistence, standardization protocols, and immunological considerations. MT represents a paradigm-shifting approach to cardiovascular therapeutics with encouraging preclinical results. Rigorous clinical trials with standardized methodologies are essential to establish safety, efficacy, and optimal implementation strategies for clinical translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Chung-Ang University Hospital, College of Medicine, Chung-Ang University, Seoul, Korea.
- Department of Physiology, College of Medicine, Chung-Ang University, Seoul, Korea.
- Department of Chemistry, Chung-Ang University, Seoul, Korea.
- College of Pharmacy, Chung-Ang University, Seoul, Korea.
- Laboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, NY, USA.
- Department of Emergency Medicine, Donald and Barbara Zucker, School of Medicine at Hofstra/Northwell, Hempstead, NY, USA. khayashida@northwell.edu.
ORCID-Profile: Suin Park, Jehee Jang, Young-Won Kim, Jae-Hong Ko, Sungguan Hong, Sung Hoon Lee, Kei Hayashida, Ki-Woon Kang
Förderung
- National Research Foundation of Korea
- Chung-Ang University
- Korean Cardiac Research Foundation
Zitieren
APA
Park, S., Jang, J., Kim, Y. W., Ko, J. H., Hong, S., Lee, S. H., Hayashida, K., & Kang, K. W. (2027). Mitochondrial Transplantation: An Emerging Therapeutic Option for Cardiovascular Disease. Korean Circulation Journal, 57. https://doi.org/10.4070/kcj.2026.0074
Vancouver
Park S, Jang J, Kim YW, Ko JH, Hong S, Lee SH, et al. Mitochondrial Transplantation: An Emerging Therapeutic Option for Cardiovascular Disease. Korean Circulation Journal. 2027;57. doi:10.4070/kcj.2026.0074
BibTeX
@article{Park2027,
author = {Park, Suin and Jang, Jehee and Kim, Young-Won and Ko, Jae-Hong and Hong, Sungguan and Lee, Sung Hoon and Hayashida, Kei and Kang, Ki-Woon},
title = {Mitochondrial Transplantation: An Emerging Therapeutic Option for Cardiovascular Disease},
journal = {Korean Circulation Journal},
year = {2027},
volume = {57},
doi = {10.4070/kcj.2026.0074}
}
EUVIMED